Atlas Trials

Testing Use of Topical Imipramine in Reducing Ultraviolet B Induced Microvesicle Particle Release in Photosensitive Subjects

Clinical trial NCT04520217 · RECRUITING

Trial details

NCT number
NCT04520217
Sponsor
Wright State University
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
PhotosensitivityMicrovesicle Particle
Start date
2022-06-06
Primary completion
2026-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.